Business and science often seem like two different worlds. The Postgraduate Diploma in Bioenterprise and Master of Bioenterprise represent new interdisciplinary programmes which aim to give science graduates the skills to move with confidence in both. The skills learned in the new programmes will allow scientists to understand and protect the value of research findings and develop or engage in their commercialisation. The programmes which are taught jointly by the School of Biological Sciences, the Graduate School of Enterprise and the Law School, cover a range of topics including breakthrough discoveries in the contemporary life sciences and their translation into high value products, the key elements of intellectual property law, the strategies for commercialisation, valuation tools and the art of writing business plans. The programmes also offer networking opportunities for students to meet practitioners and leaders from industry and business. Scientists graduating from this programme will be business-savvy and comfortable in a business environment, and may give a company a competitive edge or be the key to a successful start-up.
Course expectations and graduate profile
Graduates will have a solid understanding of the fundamental principles of contemporary research in the life sciences. They will be able to recognise the potential of high value products or processes to be developed from basic discoveries, and know how to protect the intellectual property. Graduates will be able to work together with business people in developing strategies for the commercialisation of research, and securing the capital required for this process. They will be familiar with the regulatory environments relevant to product development. They will also be able to work for investment firms in carrying out research valuations and due diligence of start-up and advanced companies.
Biotechnology industry including pharmaceutical, core biotech companies, bio-medial/device companies, agri-business, bio-processes companies, food & beverages industry, business-development firms, investment banking firms and investors such as venture capital firms, investment firms, Government agencies, tertiary education sector, technology transfer offices at Universities and CRIs.